pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG
BRIGHT MINDS BIOSCIENCES
BRIGHT MINDS BIOSCIENCES INC.
BRIGHT MINDS BIOSCIENCES clinical programs — 1063 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 19 Vestry St, New York, NY 10013, US
- Employees
- 12
- Programs
- 1063
- Drugs
- 444
- Patents
- 57
BRIGHT MINDS BIOSCIENCES projects
1,063 ClinicalTrials.gov programs sponsored by BRIGHT MINDS BIOSCIENCES.
BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
fMRI
BRIGHT MINDS BIOSCIENCES INC.
Substance Use
1 trial -
isoniazid
BRIGHT MINDS BIOSCIENCES INC.
Tuberculosis
1 trial -
naloxone nasal spray kit
BRIGHT MINDS BIOSCIENCES INC.
Drug Overdose
1 trial -
repetitive transcranial magnetic stimulation (rTMS)
BRIGHT MINDS BIOSCIENCES INC.
Amphetamine Addiction
1 trial -
tiered/titrated vitamin D dosing
BRIGHT MINDS BIOSCIENCES INC.
HIV-associated Co-morbidities
1 trial -
transdermal nicotine patches
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use
1 trial -
zinc
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial
Frequently asked questions
How many clinical projects does BRIGHT MINDS BIOSCIENCES have?
1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.